Key result
Thrombolytic agents provide more rapid clot resolution, lung reperfusion, and hemodynamic reversal compared to heparin in patients with venous thromboembolism.
Why the study?
Do thrombolytic agents improve clot resolution and hemodynamics compared to heparin in patients with venous thromboembolism?
Population
Patients with venous thromboembolism (including pulmonary embolism)
Comparison
Thrombolytic agents vs Heparin
Design
Review
Authors
Loading...
May accelerate reperfusion in VTE; leaves open net clinical benefit versus bleeding risk in routine practice.
Do thrombolytic agents improve clot resolution and hemodynamics compared to heparin in patients with venous thromboembolism?
Thrombolytic therapy offers short- and long-term benefits over heparin in venous thromboembolism by improving clot resolution, hemodynamics, and preserving venous valves.
Arthur A. Sasahara (1982) conducted a review in Venous thromboembolism. Thrombolytic agents vs. Heparin was evaluated. Thrombolytic agents provide more rapid clot resolution, lung reperfusion, and hemodynamic reversal compared to heparin in patients with venous thromboembolism.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: